Radar · Industry landscape · Germany
Life Sciences Landscape of Germany
2,428 Life Sciences companies in Germany, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated August 2026.
2,428companies tracked
$14.4Bdisclosed funding
224hiring right now
958events · 24 months
22,794news articles · 12 months
Who leads Life Sciences in Germany
Tracks 2,428 German life‑sciences firms, highlighting which companies are hiring, which have recent funding rounds, and the top performers in hiring, funding and coverage.
open roles
Hiring now
ranked by live open roles
- 01
Siemens Healthineers13last posted Aug 2026
- 02
implantcast11last posted Jun 2026
- 03
Miltenyi Biotec10last posted May 2026
- 04
Leica Biosystems10last posted Aug 2026
- 05
Brainlab10last posted Jun 2026
- 06
ADVITOS10last posted Jun 2026
- 07
Flemming Dental10last posted Jun 2026
- 08
Kulzer9last posted May 2026
224 companies hiring · 5 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
- 01
BioNTech$1.8BPost IPO · Apr 2022
- 02
CureVac$1.4BGrant (prize money) · Sep 2020
- 03
ITM$987.3MConventional Debt · May 2025
- 04
MorphoSys$770.1MPost IPO · Oct 2020
- 05
Better Place$710.8MConventional Debt · Aug 2012
- 06
Tubulis Technologies$616.7MSeries C · Oct 2025
- 07
Evotec$422.6MGrant (prize money) · Jan 2026
- 08
Viewraysystems$333.3MPost IPO · Dec 2018
428 companies with disclosed rounds · $14.4B total
revenue
Revenue leaders
official filings first, else latest snapshot
- 01
- 02
- 03
- 04
Bentley InnoMed$86.7MFY2022 filing
- 05
OPED$62MFY2021 filing
- 06
MAVIG$54.5MFY2024 filing
- 07
Centogene$53.2MFY2019 filing
- 08
Examion$31.2MFY2022 filing
35 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
- 01
- 02
Pfeiffer-Vacuum3,444tracked employees
- 03
Auxilium2,352tracked employees
- 04
geers2,000tracked employees
- 05
Stratec Biomedical1,512tracked employees
- 06
Otto Bock1,460tracked employees
- 07
Sartorius1,235tracked employees
- 08
Maquet Cardiopulmonary1,000tracked employees
163 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
- 01
- 02
- 03
- 04
- 05
- 06
Pentixa pharm3.4%45 tracked events
- 07
- 08
AAP Implantate2.5%33 tracked events
1,330 tracked events across 118 companies
articles
In the news
Prism news coverage, last 12 months
- 01
- 02
- 03
Karl Storz85articles in the window
- 04
- 05
- 06
- 07
- 08
Leica Microsystems68articles in the window
129 of these companies drew sector coverage in the window
Radar
See all 2,428 Life Sciences companies in Germany
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in Germany grew, 2016–2025
Shows the annual count of new life‑sciences companies from 2016 to 2025, with the highest number (94) in 2016 and only four founded in 2025.
Companies founded / year
new Life Sciences companies in Germany
20162025
peak 94 in 2016
Companies raising / year
with a disclosed round that year
20162025
peak 79 in 2019
Disclosed funding / year
sum of disclosed rounds (USD)
20162025
peak $3.3B in 2020
Where Life Sciences companies in Germany are based
Hub 01
Berlin
263 Life Sciences companies
37% of the Life Sciences companies across these hubs
263companies
$1.3Bdisclosed funding
30hiring now
Hub 02
Munich
148 Life Sciences companies
21% of the Life Sciences companies across these hubs
148companies
$2.9Bdisclosed funding
16hiring now
Hub 03
Hamburg
91 Life Sciences companies
13% of the Life Sciences companies across these hubs
91companies
$597.5Mdisclosed funding
12hiring now
Hub 04
Heidelberg
53 Life Sciences companies
7% of the Life Sciences companies across these hubs
53companies
$373.5Mdisclosed funding
6hiring now
Hub 05
Planegg
47 Life Sciences companies
7% of the Life Sciences companies across these hubs
47companies
$1.4Bdisclosed funding
3hiring now
Hub 06
Cologne
39 Life Sciences companies
6% of the Life Sciences companies across these hubs
39companies
$142.8Mdisclosed funding
3hiring now
Hub 07
Jena
35 Life Sciences companies
5% of the Life Sciences companies across these hubs
35companies
$83.4Mdisclosed funding
2hiring now
Hub 08
Leipzig
33 Life Sciences companies
5% of the Life Sciences companies across these hubs
33companies
$11.1Mdisclosed funding
3hiring now
The Life Sciences market map of Germany: what these companies actually do
Breaks down the main product categories and revenue models of German life‑sciences firms, noting enterprise tech as the largest sub‑category and physical commerce as the most common revenue model.
- Enterprise Tech1,510 companies · $12.3B raised · 149 hiring
- Medical Devices570 companies · $2.1B raised · 70 hiring
- Healthtech388 companies · $984.2M raised · 36 hiring
- Enterprise Software369 companies · $471.4M raised · 38 hiring
- Deep Tech316 companies · $2.1B raised · 23 hiring
- Consumer Digital273 companies · $1.3B raised · 28 hiring
- Biopharmaceuticals242 companies · $9.3B raised · 19 hiring
- SaaS113 companies · $788.1M raised · 11 hiring
- In Vitro Diagnostics110 companies · $448.5M raised · 10 hiring
- Healthtech SaaS83 companies · $43.3M raised · 6 hiring
- Nutritional Formula66 companies · $12.6M raised · 8 hiring
- Chronic Disease Management62 companies · $130.1M raised · 3 hiring
Monetization
How Life Sciences companies make money
How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Physical Commerce1,267
E-Commerce - Product1,090
Subscription627
Fee-For-Service405
Commission on Transaction79
Advertising59
E-Commerce - Service36
Licensing3
Funding, M&A and the deals moving Life Sciences in Germany
Counts 958 corporate events over the past two years, including earnings releases, funding rounds, key‑person announcements, mergers and acquisitions, and other company announcements.
Earnings 184Funding 171Leadership 152M&A 135Announcement 77Contracts 52IPO 46Board Updates 37Capital 28Assets 25
- FundingThe round includes existing investors like MIG Fonds and Bayern Kapital.2026-04-30
- FundingGermany-based Aignostics is applying artificial intelligence to drug development, aiming to improve both efficiency and patient outcomes.2026-04-27
- M&ABusiness Deal Asahi Kasei Completes Acquisition of German-based Biopharmaceutical Firm Aicuris2026-04-21
- Fundingbrainjo raised €2M seed round for VR ADHD Therapy.2026-04-20
- FundingMunich-based digital health startup XO Life has closed a new €4 million funding round.2026-04-15
- M&Aco-founded AexeRNA Therapeutics — which was itself acquired by BioNTech.2026-04-14
- FundingEvanium - raised a funding of $2.58M in Seed round held on Apr 14, 2026.2026-04-14
- M&AEvotec expects to receive initial proceeds of around 100 million dollars from the sale of its stake.2026-04-09
- FundingInsight Health secured $11 million in a Series A round led by Standard Capital, with participation from Pear VC, Kindred Ventures, Eudemian, ElevenLabs, and 43.2026-04-06
- FundingOn Wednesday, the Schönefeld-based biopharmaceutical company announced an additional €10 million in Series A financing, taking its total Series A to €23 million.2026-03-18
Mergers and acquisitions
Deals from the last 24 months where a Life Sciences company in Germany was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
| Acquirer | Target | Deal value | Status | Date |
|---|---|---|---|---|
| $11.1B | Announced | 2026-06-02 | ||
| undisclosed | Completed | 2026-04-21 | ||
| AexeRNA Therapeutics | undisclosed | — | 2026-04-14 | |
| $3.1B | Announced | 2026-04-12 | ||
| undisclosed | Announced | 2026-03-11 | ||
| Ashai Kasei | undisclosed | Announced | 2026-02-26 |
Who is listing, hiring leaders, launching and winning work
Provides details on notable events such as IPO filings, leadership changes, product launches and contract wins within the sector.
IPO pipeline
19 companies listed or filing · last 24 months
VERAXASPAC · NASDAQ · 3 reportsNov 2025
ATAIFollow-on Offering · NASDAQ · ATAI · 3 reportsOct 2025
ImmaticsSPAC · Nasdaq · IMTX · 3 reportsSep 2025
Aspreva PharmaceuticsIPO · TSX · ASPV · 5 reportsFeb 2025
JeriniIPO · Germany · 1 reportFeb 2025
Leadership moves
49 tracked people moves · last 12 months
Heidelberg PharmaPeter Willinger · Appointment → Chief Financial OfficerApr 2026
Contract wins
21 customer wins · last 24 months
Workforce actions
9 companies cutting roles · last 24 months
GPC Biotech~253 roles reported · product failureFeb 2025
Regulatory & litigation
17 regulatory events · 5 tracked suits · 24 months
- bayer v pfizer, biontech, moderna, johnson & johnsonpatent infringementJan 2026
- orchid pharma v allecra therapeutics, allecra therapeuticsAsset acquisition in insolvency proceeding · VerdictAug 2025
Earnings pulse
companies reporting results · last 24 months
24 companies reporting190 company-quarters trackedbeat 15miss 4in line 7
Half of these companies grew revenue faster than +5.0%, half slower.
Who is building Life Sciences in Germany
Profiles 1,632 founders and CEOs across 1,188 companies, showing their most frequent alma maters and prior employers.
Founders and chief executives12 of 1,632, from the best-funded companies on this page
Ex-Max Planck Institute for Biochemistry. Heidelberg University 1978, University of California PhD 1982
ex-FMP Berlin, YES!Delft. Humboldt University of Berlin 2017, HHU BSc 2011 & MSc 2012
Universities of Dresden PhD
Ex-CEO AplaGen, Kienbaum managemnet Consultants. Heinrich Heine University Düsseldorf
Ex-IFB Halle, Prosidion.
Ex-CEO 4SC. University of Wurzburg PhD
Ex-CEO Epigenomics, AltheaDx, RGTN, Enigma Diagnostics, Hologic, Leo Burnett. Purdue University Daniels School of Business BS 1992…
Ex-B.R.A.H.M.S, Sphingotec Therapeutics, Adrenomed.
Ex-CEO Jenowis, Jerini, Carl-Zeiss, MorphoSys. University of Munich PhD
Where the founders studied
alma mater on record for 79 of 1,632 founders
Technical University of Munich13
University of Cambridge9
RWTH Aachen University6
Harvard Business School5
Imperial College London5
Stanford University4
Technische Universität Berlin4
INSEAD4
Where they worked before
a previous employer on record for 10 of 1,632 founders
Boston Consulting Group5
McKinsey3
Intel1
Google1
Founders flagged as repeat founders
of 1,301 founders with a profile on this page
4
carry a repeat-founder flag
- flagged as repeat founders4
- no repeat-founder flag1,297
Radar
Look up the people behind Life Sciences companies in Germany
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in Germany
Records 916 funding rounds since 2016 from 622 investors, with a typical round size of $1.6 million.
| Investor · most active investors since 2016 | Rounds | Led | Latest |
|---|---|---|---|
| Europa | 288 | — | Mar 2026 |
| HTGF | 91 | 46 | May 2026 |
| EIC Fund | 53 | 3 | Sep 2024 |
| Bayern Kapital | 30 | 8 | Apr 2026 |
| Boehringer Ingelheim Venture Fund | 22 | 9 | Apr 2026 |
| Wellington Partners Venture Capital | 15 | 9 | Apr 2025 |
| Brandenburg Capital | 15 | 8 | Mar 2026 |
| IBB Ventures | 15 | 5 | Apr 2026 |
| EIT Health | 15 | 3 | Jul 2020 |
| OCCIDENT | 12 | 6 | Oct 2025 |
Stage mix · rounds since 2016
Seed & Angel173
Series A–B181
Series C+ / PE61
Grants, debt & other501
The typical round is $1.6M — half were bigger, half smaller.
The biggest Life Sciences funding rounds in Germany
Highlights the ten largest disclosed funding rounds, including the biggest—Tubulis Technologies’ $401 million Series C.
| Company | Round | Size | When | Backers |
|---|---|---|---|---|
| Series Cmega-round | $401M | Oct 2025 | Venrock, Wellington, Ascenta Capital +13 more | |
| Series Cmega-round | $350M | May 2010 | — | |
| Series Fmega-round | $343M | Jun 2020 | Bundesregierung | |
| Series Bmega-round | $325M | Jul 2019 | Fidelity Investments, Redmile Group, Mirae Asset +6 more | |
| Series Emega-round | $273M | Jun 2023 | Temasek, Nextech Invest, Qatar Investment Authority +3 more | |
| Series Amega-round | $270M | Jan 2018 | Redmile Group, Janus Henderson Investors, Invus +1 more | |
| Series E | $204.4M | Jun 2024 | Temasek, BlackRock, Qatar Investment Authority +2 more | |
| Series C | $200M | Nov 2011 | GE Capital, UBS, Israel Corp +3 more | |
| Series F | $171M | Jul 2020 | GSK | |
| Series D | $150M | Jul 2024 | Canaan, Bioqube Ventures, Forbion +6 more |
Venture round sizes · 2023–2025
<$1M5
$1–10M40
$10–50M18
$50–250M6
>$250M2
71 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Seed$3.4MMay 2026
Seed$2.9MMay 2026
Series A$14.1MApr 2026
Seed$12.9MApr 2026
Seed$2.6MApr 2026
Seed$2.4MApr 2026
Seed$469kApr 2026
Series A$11.5MMar 2026
What the news says about Life Sciences in Germany
Counts 22,794 news articles in the last year, covering topics such as vaccine development, drug pricing, oncology advances and rare‑disease therapies.
News volume
Life Sciences coverage across Germany · articles per quarter
2021Q22026Q1
peak 16,731 in 2025Q1 · 22,794 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative)
202120232025
Positive-tone share moved 73% → 87%, negative 25% → 11% across 2021–2025.
What the coverage is about
The subjects that dominate Life Sciences news in Germany. The arrow shows whether each one is being written about more or less than a year ago.
- Covid-19 vaccine development and efficacy trials3,993▲+64%
- Drug pricing and reimbursement strategies3,563▲+18%
- Oncology and targeted therapy advancements3,124▼-11%
- Rare disease therapies and orphan drugs2,566▼-31%
- Covid-19 vaccination campaigns and rollout strategies2,402▲+124%
- Gene therapy and crispr technologies2,377▼-31%
- Pharmaceutical marketing and sales strategies2,257▲+35%
- Generic drug development and market trends2,117→+8%
- Vaccine research and production methods2,039▼-22%
- Biotechnology innovations in medicine1,636▲+12%
Most-covered companies · last 12 months
- 700
- 149
- 85
- 84
- 83
- 76
- 75
- 68
- 42
- 39
129 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in Germany as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter
Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
vaccine candidates+104%vaccine trials+86%vaccination campaigns+158%vaccine immunogenicity+89%smart packaging+243%mass vaccination sites+386%temperature-sensitive packaging+327%anti-counterfeiting packaging+262%continuous manufacturing+215%
stem cell banking-38%diagnostic biotechnology-58%biosimilar approval-40%cell-based therapies-52%gene therapy rare diseases-38%
The pressures the press keeps returning to
Three recurring angles in Germany Life Sciences coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk ▲ rising
31,559 articles touch this dimension · 42.8% critical tone
20212025
signals: vaccine candidates, vaccine trials, stem cell banking
Funding Momentum ▲ rising
12,129 articles touch this dimension · 47.7% critical tone
20212025
signals: therapeutic development funding, biotech incubator, vaccine innovation funding
Growth ▲ rising
31,788 articles touch this dimension · 31.7% critical tone
20212025
signals: biosimilar market entry, generic drug approval, drug distribution
Life Sciences jobs in Germany: who is hiring and what they ask for
Lists 985 job postings from 109 employers in the past year, emphasizing sought‑after skills like Python, API development and workflow automation.
985postings · last 12 months
2,319postings tracked overall
109employers advertising
Demand
The Skills Employers Ask For
What Life Sciences employers in Germany put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
- python1→
- database1▼
- api development1→
- ui integration1▲
- workflow automation1▼
What level are these roles?
Entry30
Intern43
Senior189
Lead125
Manager369
Most advertised titles
- 13
- 11
- 11
- 10
- 9
- 9
What Life Sciences research is working on
Indexes 53,147 academic papers, categorising them into identified problems, cautions and opportunities.
How this field talks about itself
Life Sciences papers (gold) against all published research (grey)
Descriptive40.2% · 17.5%2.3×
Promising30.4% · 36.6%0.8×
Breakthrough14.1% · 26.5%0.5×
Problem-identifying8.3% · 9.9%0.8×
Cautionary3.5% · 4.2%0.8×
Comparative2.4% · 4.2%0.6×
Life Sciences literature runs 2.3× more “descriptive” than science at large (40.2% vs 17.5% baseline).
How the work is done
Empirical48.8%
Reviews37.2%
Methods-led11.2%
Position pieces2.2%
Theoretical0.6%
How the research reads
80% positive · 16% neutral · 4% negative, across 53,147 papers.
The institutions behind the field
- 87k
- 75k
- 61k
- 49k
- 43k
- 38k
ranked by how often their work is cited
Researchers who shaped it
Ahmad Almilaji · Reiki Nishimura · Tomofumi Osako · Yasuyuki Nishiyama · Rumiko Tashima · Masahiro Nakano · Glenn R. Gibson · Gregor Reid
The most-cited breakthroughs
- Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity · 9k cites
- In situ click chemistry generation of cyclooxygenase-2 inhibitors · 8k cites
- U1 snRNP regulates cancer cell migration and invasion in vitro · 7k cites
- Comprehensive molecular profiling of lung adenocarcinoma · 6k cites
- Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal · 6k cites
Common problems researchers identify4,503 papers · 7 recurring themes
Problems · theme 01
Sustainable Biofuel and Biomass Production
781 papers · 17.3% of this block
▲ +11% share2022→2025 share of research on this subject
Challenges in using microbes and plants for renewable fuels and biorefinery processes.
Biofuel · Synthetic biology · Biomass · Biorefinery
“A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application”
781 of these papers raise it as a problem
Problems · theme 02
Food Safety and Processing Risks
757 papers · 16.8% of this block
▲ +41% share2022→2025 share of research on this subject
Issues surrounding microbial hazards, nutritional quality, and health impacts of processed foods.
Food safety · Food processing · Food products · Human health
“Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures”
757 of these papers raise it as a problem
Problems · theme 03
Gene and mRNA Technology Hurdles
711 papers · 15.8% of this block
▼ -31% share2022→2025 share of research on this subject
Barriers in gene expression, mRNA therapeutics, and cell‑culture platforms for biomedical research.
Messenger RNA · Gene · Cell culture · Gene expression
“Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research”
711 of these papers raise it as a problem
Problems · theme 04
Crop Nutrition and Food Security
693 papers · 15.4% of this block
▲ +23% share2022→2025 share of research on this subject
Problems linked to fertilizer use, nutrient efficiency, and germplasm improvement for stable yields.
Agriculture · Crop · Food security · Germplasm
“Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants”
693 of these papers raise it as a problem
Problems · theme 05
Plant Disease and Pest Management
691 papers · 15.3% of this block
▲ +35% share2022→2025 share of research on this subject
Complexities of host‑pathogen interactions, fungicide resistance, and integrated pest control strategies.
Fungicide · Integrated pest management · Host · Disease management
“Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens”
691 of these papers raise it as a problem
Problems · theme 06
Antimicrobial Resistance Across Sectors
447 papers · 9.9% of this block
▲ +10% share2022→2025 share of research on this subject
Rising resistance in humans, livestock, and the environment threatening treatment effectiveness.
Antibiotic resistance · Antimicrobial · Antibiotics · Drug resistance
“Antimicrobial resistance in humans, livestock and the wider environment”
447 of these papers raise it as a problem
Problems · theme 07
Miscellaneous Biological and Chemical Issues
423 papers · 9.4% of this block
▼ -32% share2022→2025 share of research on this subject
Broad, less‑focused concerns spanning molecular order, metabolism, and interdisciplinary research gaps.
Order · NAD+ kinase · Human being · Sodium
“Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar”
423 of these papers raise it as a problem
Cautions1,765 papers · 7 recurring themes
Cautions · theme 01
Cellular Toxicity and Oxidative Stress
379 papers · 21.5% of this block
▼ -20% share2022→2025 share of research on this subject
Need for careful interpretation of in‑vitro and in‑vivo assays measuring stress and viability.
In vivo · Flow cytometry · In vitro · Oxidative stress
“Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells”
379 of these papers raise it as a problem
Cautions · theme 02
Genomic Selection in Plant Breeding
257 papers · 14.6% of this block
▲ +25% share2022→2025 share of research on this subject
Caution over translating genomic predictions into reliable trait improvements for crops.
Agriculture · Selection · Production · Trait
“Genomic selection in plant breeding: from theory to practice”
257 of these papers raise it as a problem
Cautions · theme 03
Feed Additives and Animal Nutrition
245 papers · 13.9% of this block
▼ -17% share2022→2025 share of research on this subject
Potential unintended effects of bioactive feed compounds on animal health and sustainability.
Feed additive · Animal feed · Feed conversion ratio · Health benefits
“Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production”
245 of these papers raise it as a problem
Cautions · theme 04
Food Contaminants and Regulatory Safety
240 papers · 13.6% of this block
▲ +14% share2022→2025 share of research on this subject
Uncertainties surrounding novel food ingredients, additives, and their compliance with safety standards.
Food safety · Hygiene · Contamination · Food contaminant
“Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters”
240 of these papers raise it as a problem
Cautions · theme 05
DNA Damage and Repair Mechanisms
239 papers · 13.5% of this block
▼ -32% share2022→2025 share of research on this subject
Complexities in interpreting gene‑expression changes related to genomic stability and disease.
Gene · DNA damage · DNA repair · Gene expression
“Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations”
239 of these papers raise it as a problem
Cautions · theme 06
Antibiotic Use and Co‑Selection Pressures
206 papers · 11.7% of this block
▲ +10% share2022→2025 share of research on this subject
Risks of simultaneous resistance development to antibiotics, biocides, and heavy metals.
Antibiotic resistance · Antibiotics · Antimicrobial · Bacteria
“Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses”
206 of these papers raise it as a problem
Cautions · theme 07
Pesticide Resistance Management
199 papers · 11.3% of this block
▲ +16% share2022→2025 share of research on this subject
Challenges in designing dose strategies and biological controls to curb evolving pest resistance.
Pesticide · Integrated pest management · PEST analysis · Biological pest control
“The use of fungal entomopathogens as endophytes in biological control: a review”
199 of these papers raise it as a problem
Opportunities22,038 papers · 7 recurring themes
Opportunities · theme 01
Advanced Antibody and Imaging Tools
1,044 papers · 17.4% of this block
▼ -18% share2022→2025 share of research on this subject
Promising platforms using fluorescent antibodies and flow cytometry for in‑vivo diagnostics.
Antibody · In vivo · Fluorescence · Flow cytometry
“Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom”
Opportunities · theme 02
Gene Regulation for Therapeutic Targets
1,032 papers · 17.2% of this block
▼ -26% share2022→2025 share of research on this subject
Opportunities in modulating apoptosis and cell growth through knockdown and up‑regulation techniques.
Downregulation and upregulation · Apoptosis · Gene knockdown · Cell growth
“Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc”
Opportunities · theme 03
Functional Plant‑Based Foods
878 papers · 14.6% of this block
▲ +68% share2022→2025 share of research on this subject
Emerging health‑focused ingredients and antioxidants from plant sources for sustainable diets.
Health benefits · Functional food · Ingredient · Antioxidant
“Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives”
Opportunities · theme 04
Epigenetic and RNA‑Based Diagnostics
823 papers · 13.7% of this block
▼ -32% share2022→2025 share of research on this subject
Innovations in DNA methylation profiling and messenger‑RNA detection for disease monitoring.
Gene · DNA methylation · Messenger RNA · DNA damage
“Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders”
Opportunities · theme 05
Novel Antimicrobials and Postbiotics
809 papers · 13.5% of this block
▲ +25% share2022→2025 share of research on this subject
Exploration of plant‑derived compounds and microbial metabolites to combat resistance.
Antimicrobial · Antibiotic resistance · Biological pest control · Bacteria
“Plants as sources of new antimicrobials and resistance-modifying agents”
Opportunities · theme 06
Genetic Improvement of Germplasm
717 papers · 11.9% of this block
▼ -22% share2022→2025 share of research on this subject
Leveraging quantitative trait loci and selection to boost crop yield and quality.
Germplasm · Trait · Quantitative trait locus · Selection
“Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield”
Opportunities · theme 07
Sustainable Biomass and Biofuel Strategies
697 papers · 11.6% of this block
▲ +29% share2022→2025 share of research on this subject
Utilizing microbial fermentation and agri‑food by‑products for eco‑friendly energy and materials.
Biomass · Sustainability · Agriculture · Biofuel
“Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health”
Which of these themes are growing fastest
Tracks how the share of research themes changes globally between 2022 and 2025.
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Food Safety and Processing Risks▲+41%
Plant Disease and Pest Management▲+35%
Crop Nutrition and Food Security▲+23%
Sustainable Biofuel and Biomass Production▲+11%
Antimicrobial Resistance Across Sectors▲+10%
Gene and mRNA Technology Hurdles▼-31%
Miscellaneous Biological and Chemical Issues▼-32%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Genomic Selection in Plant Breeding▲+25%
Pesticide Resistance Management▲+16%
Food Contaminants and Regulatory Safety▲+14%
Antibiotic Use and Co‑Selection Pressures▲+10%
Feed Additives and Animal Nutrition▼-17%
Cellular Toxicity and Oxidative Stress▼-20%
DNA Damage and Repair Mechanisms▼-32%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Functional Plant‑Based Foods▲+68%
Sustainable Biomass and Biofuel Strategies▲+29%
Novel Antimicrobials and Postbiotics▲+25%
Advanced Antibody and Imaging Tools▼-18%
Genetic Improvement of Germplasm▼-22%
Gene Regulation for Therapeutic Targets▼-26%
Epigenetic and RNA‑Based Diagnostics▼-32%
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
Keep going
Track Life Sciences in Germany beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news and research trackers, covering Germany. Counts are of companies we track, not of every company that exists. Updated August 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.